Thks .. this is from earnings call .. so I was not the only one asking this Q
Yes, thanks, Yale. So we've never disclosed the exact powering in the study. What we said previously I believe was -- is at least 80% power at the 1 milligram dose and I think we may say at least 95% powered on the two milligram dose. I'd say we're right around 80% powered at the 1 milligram dose and we're over 95% powered at the two milligram dose. The initial powering numbers that we discussed on a prior call were based on 120 patients. We enrolled 108 patients I think with 108 we're still very well powered similarly powered as to what we had previously said on the prior earnings call.